en | fr


DOWNLOADS (for participants only, password required)

 POWERPOINT PRESENTATIONS

 

ABSTRACTS & BIO  ¦ WORKING GROUP SESSIONS INFORMATION

ARTICLES FOR WGS-1  ¦ ARTICLES FOR WGS-2  ¦ ARTICLES FOR WGS-3  ¦ ARTICLES FOR WGS-4


 

THE HUMAN BODY AS A SOURCE FOR THERAPEUTICS :

Ethical , Medical and Legal implications

 

REGISTRATION ONLY OPEN FOR THE SYMPOSIUM

 

FULL SCHEDULE 

 

The 2009 Brocher Summer School will focus on the “Human Body as a Source for Therapeutics”. It will explore key issues in development of new therapeutics and related implications for the Human being and its body. A  substantive focus will be given on the following topics :

 

·          The use of parts of the Human body in medicine

·          The history of the first transplants

·          Legal principles and ethical issues related to the medical use of parts of the human body

·          Infertility and Assisted Reproduction, Status of the embryo, Comparative analysis of public policy, controversies

·          The Eurotransplant program, Living donors issues

·          Predictive medicine, medical aspects, Insurance & Predictive medicine : the Ethical and Economical aspects

·          Biobanks, medical & ethical issues, legal principles

·          Symposium on stem cells research

 

Morning and Afternoon lectures

 

Ø       Interdisciplinary approach

Ø       Internationally-renowned professors

Ø       Participation of high-level experts from the WHO

Ø       Daily class discussions

 

Afternoon workshops

 

Ø       In-depth and small-group study of selected issues addressed in morning and afternoon lectures

 

Symposium “From Promise to Practice: A new epoch for Stem Cell Research “

 

Ø       Open to an international attendance.

 

Closing Roundtable on the Human Body as a source for therapeutics

 

 

MONDAY 31st AUGUST

 

MORNING

Chair : Vincent Barras

Professor at the Faculty of Biology and Medicine, University Institute of the History of Medicine and Public Health, Lausanne (Switzerland)

 

The use of Human Body in medicines

Christian Bonah

Historian and Doctor – Louis Pasteur University, Strasbourg (France)

 

The history of the first Transplants

Susan E. Lederer

Chair of the Dpt of Medical History and Bioethics, School of Medicine and Public Health, University of Wisconsin (USA)

 

Followed by a discussion

 

AFTERNOON

Chair : Philippe Ducor

Director of the Interdisciplinary Master in Life Sciences and Law, University of Geneva (Switzerland)

 

Legal principles and their categorization

Olivier Guillod

Director of the Institute for Medical Law, University of Neuchâtel (Switzerland)

 

Legal and Ethical issues

Trudo Lemmens

Professor, Faculty of Law and Medicine, University of Toronto (Canada)

 

Working group sessions

 


TUESDAY 1st SEPTEMBER

 


MORNING

Chair : Dr Sheryl Vanderpoels

WHO, Medical Officer, Geneva (Switzerland)

 

Infertility and Assisted Reproduction : medical introduction

Yvon Englert

Head of dept of Gynaecology and Obstetrics, Erasmus Hospital, Brussels (Belgium)

 

Status of the Embryo

Alex Mauron

Professor of Bioethics, Medical Faculty, Geneva (Switzerland)

 

Followed by a discussion

 

AFTERNOON

Chair : Yvon Englert

Professor and Chief of Gynaecology and Obstetrics, Erasmus Hospital, Brussels (Belgium)

 

Assisted Reproduction : Comparative analysis of public policy

Frédéric Varone

Professor at the Economic and Social Sciences, University of Geneva (Switzerland)

 

Controversy on : “Should multiple deliveries be considered as success?”

Allan Templeton

Professor of Obstetrics and Gynaecology, University of Aberdeen (UK)

 

René Frydman

Professor, Faculty of Medicine, University Paris XI and Head of the Department of Gynecology and Obstetrics of Antoine Beclere Hospital, Director of Research Unit on Reproductive medecine

 

 

Working group sessions

WEDNESDAY 2nd SEPTEMBER

 

MORNING

Chair : Philippe Ducor,

Director of the Interdisciplinary Master in Life Sciences and Law, University of Geneva (Switzerland)

 

The Eurotransplant program

Frans Claas

Member of the Eurotransplant, Erasmus Hospital, Geneva (Switzerland)

 

Living donor issues

Pierre-Yves Martin

Professor and Chairman, Dpt of Nephrology, University of Geneva (Switzerland)

 

Followed by a discussion

 

WHO – Brief introduction to the objectives of the Ethics and Health Unit

Dr Marie Charlotte Bouësseau

Ethics and Health Unit, WHO, Geneva (Switzerland)

 

THURSDAY 3rd SEPTEMBER

 

MORNING

Chair : Anne Cambon-Thomsen

Chair of the INSERM Unity 558, Geneticist, Toulouse (France)

 

Predictive medicine: Medical introduction

Stylianos Antonarakis

Professor and Chairman, Dpt of Genetic Medicine and Development, University of Geneva (Switzerland)

 

Insurance & predictive medicine: the Ethical and economical aspects

Michael Hoy

Professor of Economics, University of Guelph (Canada)

Followed by a discussion

 

THURSDAY 3rd SEPTEMBER

 

AFTERNOON

Chair : Jan-Helge Solbakk

Professor, Section for Medical Ethics, Faculty of Medicine, University of Oslo (Norway)

 

Biobanks - Medical and Legal Issues

Anne Cambon-Thomsen

Chair of the INSERM Unity 558, Geneticist, Toulouse (France)

 

Biobanks - Legal Principles

Dr Jane Kaye

The Ethox Center, University of Oxford (UK)

 

Followed by a discussion

Working group sessions

 

FRIDAY 4th SEPTEMBER

 

SYMPOSIUM “From Promise to Practice: A new Epoch for Stem Cell Research”

 

MORNING SESSION : Medical and Ethical Implications

 

Stem Cells in the Clinic

Christopher Thomas Scott

Director, Stanford University Program on Stem Cells in Society

 

The Rise of Stem Cell Tourism

Timothy Caulfield

Director of Health Law, University of Alberta

 

The Embryonic Dilemma : Which disease, how safe?

Outi Hovatta

Professor of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institute

 

Roundtable Discussion

 

AFTERNOON SESSION : Political and Legal Perspectives

 

A Parliamentarian’s Perspective : Lawmaking in biology’s newest frontier

Senator Kay Patterson

Former Federal Australian Health Minister, Vice Chancellor’s Professional Fellow, University of Monash

 

A Fractured Landscape of Stem Cell Patents : Who owns what?

Aurora Plomer

Chair in Law and Bioethics, Director of SIBLE, School of Law, University of Sheffield

 

The State of the Stem Cell Industry

Paul Martin

Reader in Science and Technology Studies, Deputy Director, University of Nottingham

 

Roundtable Discussion

 

Concluding remarks

 

 

SATURDAY 5th SEPTEMBER

 

ROUNDTABLE

 

BSS Participants &

P. Ducor, Y. Englert, R. Gurny, A. Mauron, L. Scapozza.